Publicerade artiklar 2010 och 2011

Varianter av denna sida

Publikationer under 2010 och 2011:

2011

Sorbe B, Horvath G, Andersson H, Boman K, Lundgren C, Pettersson B. External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-risk Endometrial Carcinoma – A Prospective Randomized Study. Int J Radiat Oncol Biol Phys. 2011 Jun 13.

Löf-Öhlin ZM, Sorbe B, Wingren S, Nilsson TK. Hypermethylation of promoter regions of the APC1A and p16INK4a genes in relation to prognosis and tumor characteristics in cervical cancer patients. Int J Oncol. 2011 Sep;39(3):683-8. doi: 10.3892/ijo.2011.1078.

Wegman P, Ahlin C, Sorbe B. Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy. Int J Gynecol Cancer. 2011 Jan;21(1):86-91.

Skírnisdóttir IA, Sorbe B, Lindborg K, Seidal T. Prognostic impact of p53, p27 and C-MYC on clinicopathological features and outcome in early-stage (FIGO I-II) epithelial ovarian cancer. Int J Gynecol Cancer. 2011 Feb;21(2):236-44.

Löf-Öhlin ZM, Levanat S, Sabol M, Sorbe B, Nilsson TK. Promoter methylation in the PTCH gene in cervical epithelial cancer and ovarian cancer tissue as studied by eight novel Pyrosequencing® assays. Int J Oncol. 2011 Mar;38(3):685-92. doi: 10.3892/ijo.2011.895.

Ekwall E, Ternestedt BM, Sorbe B, Graneheim UH. Patients perceptions of communication with the health care team during chemotherapy for the first recurrence of ovarian cancer. Eur J Oncol Nurs. 2011 Feb;15(1):53-8.

Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM; ICON7 Investigators. A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med. 2011 Dec 29;365(26):2484-96

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Paija O, Helle L, Villman K, Nyandoto P, Nilsson G, Pajunen M, Asola R, Poikonen P, Leinonen M, Kataja V, Bono P, Lindman H. Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial. J Clin Oncol. 2012 Jan 1;30(1):11-8.

Jamshidi M, Bartkova J, Greco D, Tommiska J, Fagerholm R, Aittomäki K, Mattson J, Villman K, Vrtel R, Lukas J, Heikkilä P, Blomqvist C, Bartek J, Nevanlinna H. NQO1 expression correlates inversely with NFκB activation in human breast cancer. Breast Cancer Res Treat. 2011 Jun 25.

Margolin S, Bengtsson NO, Carlsson L, Edlund P, Hellstrøm M, Karlsson P, Lidbrink E, Linderholm B, Lindman H, Malmström P, Pettersson Skøld D, Søderberg M, Villman K, Bergh J; Scandinavian Breast Group Study SBG 2004-1. A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dosedense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer. Acta Oncol. 2011 Jan;50(1):35-41.

Baumgart J, Nilsson K, Stavreus-Evers A, Kask K, Villman K, Lindman H, Kallak T, Sundström-Poromaa I. Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol. 2011 Jan;204(1):26.e1-7.

Zackrisson B, Nilsson P, Kjellén E, Johansson KA, Modig H, Brun E, Nyman J, Friesland S, Reizenstein J, Sjödin H, Ekberg L, Lödén B, Mercke C, Fernberg JO, Franzén L, Ask A, Persson E, Wickart-Johansson G, Lewin F, Wittgren L, Björ O, Björk-Eriksson T. Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - the ARTSCAN study. Radiother Oncol. 2011 Jul;100(1):41-8.

Landström FJ, Nilsson CO, Reizenstein JA, Nordqvist K, Adamsson GB, Löfgren AL. Electroporation therapy for T1 and T2 oral tongue cancer. Acta Otolaryngol. 2011 Jun;131(6):660-4.

Johansson B, Karlsson L, Reizenstein J, von Beckerath M, Hardell L, Persliden J. Pulsed dose rate brachytherapy as the boost in combination with external beam irradiation in base of tongue cancer. Long-term results from a uniform clinical series. J Contemp Brachyther. 2011; 3, 1: 11-17.

Johansson B, Karlsson L, Hardell L, Persliden J. Long term results of PDR brachytherapy for lip cancer. J Contemp Brachyther 2011; 3, 2: 65-69.

Söderqvist F, Carlberg M, Hansson Mild K, Hardell L. Childhood brain tumour risk and its association with wireless phones: a commentary. Environ Health. 2011;10(1):106.

Hardell L, Carlberg M, and Hansson Mild K: Re-analysis of risk for glioma in relation to mobile telephone use: comparison with the results of the Interphone international case-control study. Int J Epidemiol 2011;40(4):1126-1128.

Hardell L, Carlberg M, Hansson Mild K. Pooled analysis of case-control studies on malignant brain tumours and the use of mobile and cordless phones including living and deceased subjects. Int J Oncol 2011;38(5):1465-1474.

Lai H, Hardell L. Cell phone radiofrequency radiation exposure and brain glucose metabolism. JAMA 2011;2011;305(8):828-829.

Baan R, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Islami F, Galichet L, Straif K; WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol. 2011;12(7):624-626.

Behrens T, Lynge E, Cree I, Lutz JM, Eriksson M, Guénel P, Merletti F, Morales-Suarez-Varela M, Afonso N, Stengrevics A, Févotte J, Sabroe S, Llopis-González A, Gorini G, Hardell L, Stang A, Ahrens W. Pesticide exposure in farming and forestry and the risk of uveal melanoma. Cancer Causes Control. E pub 2011 Nov 4.

Behrens T, Lynge E, Cree I, Lutz JM, Eriksson M, Guénel P, Merletti F, Morales-Suarez-Varela M, Afonso N, Stengrevics A, Stang A, Févotte J, Sabroe S, Llopis-González A, Gorini G, Hardell L, Ahrens W. Occupational exposure to endocrine-disrupting chemcials and the risk of uveal melanoma. Scand J Work Environ Health. 2011 Dec 17. pii: 3265. doi: 10.5271/sjweh.3265.

Hardell L, Carlberg M, Hansson Mild K, Eriksson M. Case-control study on the use of mobile and cordless phones and the risk for malignant melanoma in the head and neck region. Pathophysiology. 2011;18(4):325-33.

Hardell L, Carlberg M, Hansson Mild K. Pooled analysis of case-control studies on malignant brain tumours and the use of mobile and cordless phones including living and deceased cases. Ebea, Rome 2011; February 21-24, 2011.

Söderqvist F, Carlberg M, Zetterberg H, Hardell L. Use of wireless phones and serum beta-trace protein. Ebea, Rome 2011; February 21-24, 2011.

Hardell L. Fel igen om mobiltelefoni och hjärntumörer. Läkartidningen 2011; 42: 2104.

2010

Skirnisdottir I, Sorbe B. Association of BMI (Body Mass Index) with clinico-pathological factors and survival in epthelial ovarian cancer in FIGO-stages I-IV. Acta Obstet Gynecol Scand 89:101-107, 2010.

Högberg T, Signorelli M, de Oliveira CF, Fossate R, Lissoni AA, Sorbe B, Andersson H, Salminen T, Grenman S, Lundgren C, Rosenberg P, Boman K, Vuolo-Merilä P, Puistola U, Scambia G, Greggi S, Germana T, Clarke J, Kobierska A, Sawicki T, Zola P, Kristensen G. Sequential adjuvant chemotherapy added to radiotherapy in endometrial cancer at risk for micrometastatic disease - Results from two randomized studies from the Nordic Society for Gynecologic Oncology (NSGO) and the European Organization for the Research and Treatment of Cancer (EORTC) and from the Mario Negri Gynecologic Oncology Group (MaNGO). Eur J Cancer 2010; 46:2422-2431.

Sorbe B, Bohr L, Karlsson L, Bermark B. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: Predictive factors for local tumor control and early recurrences. Int J Oncol 36: 371-378, 2010.

Söderqvist F, Hardell L, Carlberg M, Hansson Mild K. Radiofrequency fields, transthyretin and Alzheimer´s disease. J Alzheimers Dis, 2010;20(2):599-606.

Hardell L, Carlberg M, Söderqvists F, Hansson Mild K. Re: Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl Cancer Inst 2010;102(10):740-741.

Khurana VG, Hardell L, Everaert J, Bortkiewicz A, Carlberg M, Ahonen M. Epidemiological evidence for health risks from mobile phone base stations. Int J Occup Environ Health 2010;16(3):263-267.

Hardell L, Carlberg M, Hansson Mild K. Mobile phone use and the risk for malignant brain tumors – a case-control study on deceased cases and controls. Neuroepidemiology 2010;35(2):109-114.

Hardell L, Söderqvist F, Carlberg M, Zetterberg H, Hansson Mild K. Exposure to wireless phone emissions and serum b-trace protein. Int J Mol Med 2010;26(2):301-306.

Behrens T, Lynge E, Cree I, Sabroe S, Lutz JM, Alfonso N, Eriksson M, Guénel P, Merletti F, Morales-Suarez-Varela M, Stengrevics A, Févotte J, Llopis-González A, Gorini G, Sharkova G, Hardell L, Ahrens W. Occupational exposure to electromagnetic fields and sex-differential risk of uveal melanoma. Occup Environ Med 2010;67(11):751-759.

Villeneuve S, Cyr D, Lynge E, Orsi L, Sabroe S, Merletti F, Gorini G, Morales-Suarez-Varela M, Ahrens W, Baumgardt-Elms C, Kaerlev L, Eriksson M, Hardell L, Févotte J, Guénel P. Occupation and occupational exposure to endocrine disrupting chemicals in male breast-cancer: a case-control study in Europe. Occup Environ Med 2010;67(12):837-844.

Fritschi L. Guénel P, Ahrens W. European study group on occupational causes of rare cancers. Breast cancer in priests – follow up of an observation made 167 years ago. Eur J Epidemiol 2010;25(3):219-21.

Schmeisser N, Kaerlev L, Bourdon-Raverdy N, Ganry O, Llopis-González A, Guénel P, Hardell L, Merletti F, Zambon P, Morales-Suarez-Varela M, Olsen J, Olsson H, Vyberg M, Ahrens W. Occupational exposure to pesticides and bile tract carcinoma in men: results from a European multicenter case-control study. Cancer Causes Control. 2010;21(9):1493-1502.

Behrens T, Kaerlev L, Cree I, Lutz JM, Alfonso N, Eriksson M, Guénel P, Merletti F, Morales-Suarez-Varela M, Stengrevics A, Sabroe S, Cyr D, Llopis-González A, Gorini G, Sharkova G, Hardell L, Ahrens W. Hormonal exposure and the risk of uveal melanoma. Cancer Causes Control 2010;21(10):1625-1634.

Hardell L. Wireless phone use and brain tumour risk. Eur J Oncol Library 2010 vol 5.

Hardell L, Carlberg M, Hansson Mild K. Re-analysis of risk for glioma in relation to mobile telephone use: comparison with the results of the Interphone international case-control study. Int J Epidemiol December 17, 2010: doi:10.1093/ije/dyq246.

Reizenstein J, Bergström S, Holmberg L, Linder A, Ekman S, Blomquist E, Lödén B, Holmqvist M, Hellström K, Nilsson C, Brattström D, Bergqvist M. The impact of age at diagnosis and treatment in laryngeal cancer. Head & Neck 2010 Aug; 32(8): 1062-1068.

Landström FJ, Nilsson CO, Crafoord S, Reizenstein J, Adamsson GB, Löfgren L. Electroporation therapy of skin cancer in the head and neck area. Dermatol Surg 2010 Aug; 36(8): 1245-1250.

Holgersson G, Ekman S, Reizenstein J, Bergqvist M, Pontén F, Uhlén M, Magnusson K, Jonnalagadda P, Asplund A, Strömberg S, Linder A, Blomquist E, Liljeholm M, Lödén B, Hellström K, Bergström S. Molecular prfiling using tissue microarrays as a tool to identify predictive bimarkers in laryngeal cancer treated with radiotherapy. Cancer Genomics Proteomics 2010 Jan-Feb; 7(1): 1-7.

 

Sid-funktioner och -information

Dela

Sidan granskades den 9 februari 2012

Innehållsansvarig: Kenneth Villman

Publicerad av Elisabeth Peippo

Tipsa en vän

Fyll i detta formulär för att tipsa en vän om den här sidan.

Fält markerade med * är obligatoriska.

En länk till den här sidan följer automatiskt med ditt meddelande.

Bifoga

Max antal filer: 5
Max total storlek: 2.0 mB
Tillåtna filtyper: *.doc, *.docx, *.gif, *.jpeg, *.jpg, *.pdf, *.rtf, *.txt, *.xls, *.xlsx